+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Uveitis Clinical Trial Pipeline Highlights - 2019

  • ID: 4773913
  • Report
  • March 2019
  • Region: Global
  • Fore Pharma
1 of 2

This report, Uveitis Pipeline Highlights - 2019, provides the most up-to-date information on key pipeline products in the global uveitis market. It covers emerging therapies for uveitis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives in tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides uveitis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides uveitis pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides uveitis pipeline products by the company.

Short-term Launch Highlights:

Find out which uveitis pipeline products will be launched in the US and Ex-US to 2024.

Summary:

  • Uveitis phase 3 clinical trial pipeline products
  • Uveitis phase 2 clinical trial pipeline products
  • Uveitis phase 1 clinical trial pipeline products
  • Uveitis preclinical research pipeline products
  • Uveitis discovery stage pipeline products
  • Uveitis pipeline products short-term launch highlights

Note: Please allow up to 48 hours for delivery after order is placed.
Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 2
1. Uveitis Pipeline by Stages

2. Uveitis Phase 3 Clinical Trial Insights

3. Uveitis Phase 2 Clinical Trial Insights

4. Uveitis Phase 1 Clinical Trial Insights

5. Uveitis Preclinical Research Insights

6. Uveitis Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables:
Table 1: Uveitis Phase 3 Clinical Trials, 2019
Table 2: Uveitis Phase 2 Clinical Trials, 2019
Table 3: Uveitis Phase 1 Clinical Trials, 2019
Table 4: Uveitis Preclinical Research, 2019
Table 5: Uveitis Discovery Stage, 2019

List of Figures:
Figure 1:: Uveitis Pipeline Molecules by Clinical Trials Stage, 2019
Figure 2: Uveitis Phase 3 Clinical Trial Highlights, 2019
Figure 3: Uveitis Phase 2 Clinical Trial Highlights, 2019
Figure 4: Uveitis Phase 1 Clinical Trial Highlights, 2019
Figure 5: Uveitis Preclinical Research Highlights, 2019
Figure 6: Uveitis Discovery Stage Highlights, 2019
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll